Eckard Weber

Partner at Domain Associates LLC

Eckard Weber

Eckard Weber

Partner at Domain Associates LLC

Overview
Career Highlights

Ascenta Therapeutics, Inc.
Sonexa Therapeutics, Inc.
Ocera Therapeutics, Inc. (Inactive)

RelSci Relationships

1491

Number of Boards

31

Birthday

1951

Age

68

Contact Data
Trying to get in touch with Eckard Weber? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Eckard Weber likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Domain Associates LLC

Relationship likelihood: Strong

Chief Executive Officer & Director at Gene Sciences, Inc.

Relationship likelihood: Strong

General Partner at Sofinnova Ventures, Inc.

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

President at Ascenta Therapeutics, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Ocera Therapeutics, Inc. (Inactive)

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Founder, Managing Director & General Partner at Montreux Equity Partners

Relationship likelihood: Strong

Founder at Domain Associates LLC

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Paths to Eckard Weber
Potential Connections via
Relationship Science
You
Eckard Weber
Partner at Domain Associates LLC
Education
MD
Class of 1979

Ulm University (German: Universität Ulm) is a public university in the city of Ulm, in the South German state of Baden-Württemberg. The university was founded in 1967 and focuses on natural sciences, medicine, engineering sciences, mathematics, economics and computer science. With 9,188 students (summer semester 2013), it is one of the youngest public universities in Germany. Times Higher Education (THE) ranks it at position 16 among the world's top 100 universities under the age of 50 years in 2014, making it the highest-ranked young university in Germany.

Career History
Chairman, Founder
2007 - 2009

Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA.

Tenured Professor of Pharmacology
Prior - 1995

University of California, Irvine is a public research university located in Irvine, California and one of the 10 general campuses in the University of California (UC) system. UCI's Orange County campus is the fifth-largest in the UC system. UC Irvine is considered a Public Ivy and became a member of the Association of American Universities in 1996, and is the youngest university to hold membership. It also administers the UC Irvine Medical Center, a large teaching hospital; the UC Irvine Health Sciences system in the City of Orange; the University of California, Irvine, Arboretum; and a portion of the University of California Natural Reserve System.

Founder
2000 - 2011

Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA.

Boards & Committees
Member, Board of Directors
2015 - Current

Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on May 4, 2015 and is headquartered in South San Francisco, CA.

Member, Board of Directors
Current

Adynxx, Inc. develops clinical-stage pharmaceutical addressing pain at its molecular roots. Its technology platform provides treating the development of pain following surgery or trauma and established chronic pain syndrome. The company was founded by Julien Mamet in October 2007 and is headquartered in San Francisco, CA.

Chairman of the Board
Current

Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA.

Political Donations
$230
2010

The Democratic Senatorial Campaign Committee is the only organization solely dedicated to electing a Democratic Senate. From grassroots organizing to candidate recruitment to providing campaign funds for tight races, the DSCC is working hard all year, every year to elect Democrats – and give President Obama the help he needs on Capitol Hill to move our country forward.

$2,300
2008

Former President of United States

$225
2004

MoveOn.org engages in promoting social and civic activities. Its services include education and advocacy on important national issues. The company was founded by by Joan Blades and Wes Boyd in 1998 and is headquartered in Greenbrae, CA.

Transactions
Details Hidden

Ocera Therapeutics, Inc. purchases Ocera Therapeutics, Inc. (Inactive) from Sofinnova Ventures, Inc., Domain Associates LLC, InterWest Partners, LLC, Thomas McNerney Ptn

Details Hidden

Sonexa Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Sonexa Therapeutics, Inc. raised money in a private placement transaction

Investments
Details Hidden

Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.

Details Hidden

Mr. Keyes joined Orexigen in January 2013 as its Vice President of Finance. Prior to joining Orexigen, Mr. Keyes was at Amylin Pharmaceuticals, Inc. as Senior Director of Finance from May 2012 to January 2013 and Director, Manufacturing, Operations and Quality Finance from August 2007 to May 2012. Previously, he worked in financial and corporate strategy at Amgen, Inc. from March 2004 to July 2007, and at Baxter Healthcare Corporation from July 2002 to March 2004. Mr. Keyes holders a B.S. and M.S. in Civil Engineering from Stanford University and an M.B.A. from the Anderson School at the University of California, Los Angeles.

Details Hidden

NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA.

Other Affiliations

Eckard Weber is affiliated with Calixa Therapeutics, Inc., University of California - Irvine, Novalar Pharmaceuticals, Inc., Novacea, Inc., Nanothera Corp., NovaCardia, Inc., Domain Associates LLC, Cytovia, Inc., Acea Pharmaceuticals, Inc., Domain Antibacterial Acquisition Corp., Konova, Inc., Tramoxia Therapeutics, Inc., Sonexa Therapeutics, Inc., Ocera Therapeutics, Inc. (Inactive), Adastra Pharmaceuticals, Inc., Tobira Therapeutics, Inc. (Inactive), Syndax Pharmaceuticals, Inc., Orexigen Therapeutics, Inc., Stanford University - School of Medicine, Sequel Pharmaceuticals, Inc., Abrexa Pharmaceuticals, Inc., Ascenta Therapeutics, Inc., Paratek Pharmaceuticals Inc., Adynxx, Inc., Tobira Therapeutics, Inc., Adynxx, Inc., Peninsula Pharmaceuticals, Inc., Domain Elite Holdings Ltd., Alyrxx, Inc., Regado Biosciences, Inc., Ocera Therapeutics, Inc., Atara Biotherapeutics, Inc., Xtegra Corp., Sonexa Therapeutics, Inc., Calixa Therapeutics, Inc., Tobira Therapeutics, Inc. (Inactive), Conforma Therapeutics Corp., Cabrellis Pharmaceuticals Corp., Syndax Pharmaceuticals, Inc., Ocera Therapeutics, Inc. (Inactive), Orexigen Therapeutics, Inc., NovaCardia, Inc., Novacea, Inc., Paratek Pharmaceuticals Inc., Ascenta Therapeutics, Inc., Adastra Pharmaceuticals, Inc., Sequel Pharmaceuticals, Inc., Pinta Biotherapeutics, Inc., Alliqua BioMedical, Inc., RightCare Solutions, Inc., Synovis Life Technologies, Inc., Pharmion Corp., Cytovia, Inc., Nanothera Corp., DiObex, Inc., BioVascular, Inc., Konova, Inc., Acea Pharmaceuticals, Inc., Domain Antibacterial Acquisition Corp., Cerexa, Inc., Santa Maria Biotherapeutics, Inc., Nina Biotherapeutics, Inc., Abrexa Pharmaceuticals, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Eckard Weber. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Eckard Weber's profile does not indicate a business or promotional relationship of any kind between RelSci and Eckard Weber.